- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Exposures in Pregnancy: Perception of Teratogenic Risk
Motherisk Research
-
Lancet. 2001 Oct 13;358(9289):1237-8.
Jasper JD, Goel R, Einarson A, Gallo M, Koren G: Effects of framing on teratogenic risk perception in pregnant women. -
J Clin Pharmacol. 2000 Jun;40(6):573-7.
Pole M, Einarson A, Pairaudeau N, Einarson T, Koren G: Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. -
Reprod Toxicol. 1999 Jul-Aug;13(4):313-9.
Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G: The perception of teratogenic risk by women with nausea and vomiting of pregnancy. -
Amer J Obstet Gynecol, 160: 1190-1194, 1989.
Koren G, Bologa-Campeneau M, Long D, Henderson K, Feldman Y, Shear, N: Perception of teratogenic risk by pregnant women exposed to drugs and chemicals in early pregnancy. -
Teratology 41: 657-661, 1990.
Koren G, Pastuszak A, Pellegrini E: Prevention of unnecessary pregnancy termination by counseling women on drug, chemical and radiation exposure during the first trimester -
Teratology 43: 109-112, 1991.
Bentur G, Horlatch N, Koren G: Exposure to ionizing radiation during pregnancy; Perception of teratogenic risk and outcome. -
Teratology 46: 567-571, 1992.
Koren G, Gladstone D, Robeson C, Robieux I: The perception of teratogenic risk of cocaine. -
November 20-21, 1990, Ottawa. Canadian Public Health Association, Health & Welfare Canada and World Health Organization.
Koren G, Pastuszak A, Bologa M: Women's perception of teratogenic risk. Proceedings of the International Symposium on "Risk Estimation for Pharmaceuticals". -
Can J Publ Health 82: S11-S14, 1991 No abstract available.
Koren G, Bologa M, Pastuszak, A: Women's perception of teratogenic risk. -
Ann N Y Acad Sci 78: 317-324, 1993. No abstract available.
Koren G, Bologa M, Pastuszak, A: How women perceive teratogenic risk and what they do about it. -
Koren G: Perception of teratogenic risk by women and their physicians. In: (G. Koren, ed) Folic acid for the prevention of neural tube defects. The Motherisk Program, 47-49, 1995.
-
Teratology, 40: 37-45, 1989.
Feldman Y, Koren G, Mattice D, Shear H, Pellegrini E, MacLeod SM: Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. -
Reprod Toxicol. 2001 Jan;15(1):1-3. No abstract available.
Koren G: Misrepresentation and miscommunication of teratogenic risk of drugs; analysis of three highly publicized international cases












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)